NCT03883945: A trial that was reported late by Aiviva BioPharma Inc.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT03883945 |
|---|---|
| Title | A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Intradermally Administered AIV001 in Subjects With Papulopustular Rosacea |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 31, 2021 |
| Completion date | July 31, 2022 |
| Required reporting date | July 31, 2023, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 19, 2022 |
| Days late | None |